Recruiting NA INTERVENTIONAL 1-arm
NCT06696326
A Multicenter Study Evaluating the Diagnostic Value of 68Ga-MY6349 PET/CT for Prostate Cancer
Sponsor: The First Affiliated Hospital of Xiamen University
Interventions
standard-of-care imaging 68Ga-MY6349 and 68Ga-PSMA-11
Updated 2 times since 2024 Last updated: Dec 16, 2024 Started: Oct 1, 2024 Primary completion: Oct 15, 2025 Completion: Oct 15, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06696326, this NA trial focuses on Positron-Emission Tomography(PET) and Prostate Cancer and remains actively recruiting participants. Sponsored by The First Affiliated Hospital of Xiamen University, it has been updated 2 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Jan 2025 — Present [monthly]
Recruiting NA
-
Dec 2024 — Jan 2025 [monthly]
Recruiting NA
First recorded
Oct 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- The First Affiliated Hospital of Xiamen University
Data source: The First Affiliated Hospital of Xiamen University
For direct contact, visit the study record on ClinicalTrials.gov .